Axabin 10,15,20®

Brand name: Arena Life Science

Generic Name: Rivaroxaban

Rivaroxaban is a highly selective direct factor Xa inhibitor with high oral bioavailability. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi.

Pharmaceutical Class: Anticoagulant

Dosage Form and Strength: Oral Film-coated tablets, 10-15-20 mg

Product Description:

INDICATIONS

  • Reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation (NVAF)
  • Treatment of deep vein thrombosis (DVT)
  • Treatment of pulmonary embolism (PE)
  • Reduction in the risk of recurrence of DVT or PE
  • Prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
  • Prophylaxis of venous thromboembolism (VTE) in acutely ill medical patients
  • Axabin® is the first generic form of rivaroxaban in Iran which is produced at a GMP approved manufacturing site

Additional Information

Additional information

Related Products

Axabin 10,15,20®

View Product

Product Images

axabin11-4 axabin11-2 axabin11